Tinnitus Sound Therapy Using Mobile Application.
Launched by DR. BASEL SAMMAN · Oct 23, 2023
Trial Information
Current as of November 12, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new way to help people with tinnitus, a condition that causes ringing or buzzing in the ears. Researchers are testing a mobile application that offers personalized sound therapy to manage tinnitus. The app aims to make it easier for people to access treatment, track their progress, and receive support, all from their smartphones. By integrating sound therapy, relaxation exercises, and educational resources into one platform, the study hopes to improve the quality of life for those suffering from chronic tinnitus.
To participate in this trial, you need to be an adult who has experienced tinnitus for more than six months, and it should be affecting your daily life in some way. You must also have a smartphone that runs on Android or iOS. Unfortunately, people with certain conditions, like severe hearing loss or those who can't use the app for other reasons, won't be eligible. This study is not yet recruiting participants, but if you qualify, you can expect to engage with the app regularly and receive personalized feedback as part of your treatment.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • - Adults.
- • Chronic tinnitus for more than 6 months.
- • Subjective tinnitus.
- • Tinnitus affecting quality of life, limiting daily life activities, and causing distress.
- • Physically and mentally fit and able to fill in the questionnaires themselves.
- • Persons who have a mobile phone with Android or iOS.
- Exclusion Criteria:
- • - Intermittent tinnitus.
- • Tinnitus not affecting quality of life, not limiting daily life activities, and not causing distress.
- • Objective tinnitus.
- • Severe or profound hearing loss.
- • No device enabling the use of the application (Patient has no mobile phone).
- • Vulnerable group of patients (Pregnant women, Patients with physical or mental disabilities, Patients older than 65 years, Children under 18 years, Prisoners, Refugees)
- • Patients with physical disabilities that prevent the patients from using the mobile.
About Dr. Basel Samman
Dr. Basel Samman is a distinguished clinical trial sponsor known for his commitment to advancing medical research and improving patient outcomes. With a robust background in clinical medicine and research, Dr. Samman leads innovative trials that focus on developing novel therapeutics and treatment modalities across various therapeutic areas. His leadership emphasizes rigorous scientific methodology, ethical standards, and collaboration with leading healthcare professionals and institutions. Driven by a passion for translating research discoveries into clinical practice, Dr. Samman is dedicated to fostering a culture of excellence and integrity in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Basel M Samman, Doctor
Principal Investigator
Ministry of Public Health Qatar
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported